Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.
作者信息
Anderson J V, Coupe M O, Morris J A, Hodgson H J, Bloom S R
出版信息
Br Med J (Clin Res Ed). 1987 May 2;294(6580):1129. doi: 10.1136/bmj.294.6580.1129.
Abstract
摘要
相似文献
1
Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.新型5-羟色胺M受体拮抗剂治疗类癌综合征的症状缓解情况
Br Med J (Clin Res Ed). 1987 May 2;294(6580):1129. doi: 10.1136/bmj.294.6580.1129.
2
The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome.
Aliment Pharmacol Ther. 1988 Apr;2(2):167-72. doi: 10.1111/j.1365-2036.1988.tb00684.x.
3
Tropisetron (ICS 205-930): a selective 5-hydroxytryptamine antagonist.
Eur J Cancer. 1993;29A Suppl 1:S30-2. doi: 10.1016/s0959-8049(05)80257-6.
4
Results of the intravenous administration of tropisetron in fibromyalgia patients.曲罗西隆静脉注射治疗纤维肌痛患者的结果。
Scand J Rheumatol Suppl. 2000;113:59-62. doi: 10.1080/030097400446661.
5
Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions--preliminary clinical experience.
Scand J Rheumatol Suppl. 2004;119:55-8. doi: 10.1080/03009740410007069.
6
Adverse reaction to 5-HT3 antagonist ICS 205930.
Lancet. 1987 Jun 27;1(8548):1494. doi: 10.1016/s0140-6736(87)92246-x.
7
8
[Pain modification by the 5-HT3 receptor antagonist tropisetron in secondary fibromyalgias].5-羟色胺3受体拮抗剂托烷司琼对继发性纤维肌痛的疼痛调节作用
Fortschr Med Orig. 2002;120(1):17-20.
9
Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.静脉注射托烷司琼治疗纤维肌痛的疗效和耐受性。
Scand J Rheumatol. 2004;33(4):267-70. doi: 10.1080/03009740410005818.
10
[Prevention and treatment of postoperative nausea and postoperative vomiting with tropisetron].
Anasthesiol Intensivmed Notfallmed Schmerzther. 1997 Oct;32(10):628-31. doi: 10.1055/s-2007-995122.
引用本文的文献
1
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.奥氮平口服可有效治疗类癌综合征腹泻，且对生长抑素类似物无反应。
Oncologist. 2019 Feb;24(2):255-258. doi: 10.1634/theoncologist.2018-0191. Epub 2018 Aug 31.
2
Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial.5-羟色胺3受体拮抗剂西兰司琼与安慰剂对健康男性乙状结肠阶段性运动的影响：一项双盲交叉试验
Br J Clin Pharmacol. 2000 May;49(5):429-36. doi: 10.1046/j.1365-2125.2000.00180.x.
3
Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine.顺铂损害大鼠小肠中液体和电解质的吸收：5-羟色胺的作用。
Gut. 1999 Feb;44(2):174-9. doi: 10.1136/gut.44.2.174.
4
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.腹泻型肠易激综合征患者餐后血浆5-羟色胺水平的初步研究
Gut. 1998 Jan;42(1):42-6. doi: 10.1136/gut.42.1.42.
5
Failure of tropisetron to inhibit jejunal water and electrolyte secretion induced by 5-hydroxytryptamine in healthy volunteers.托烷司琼未能抑制健康志愿者体内由5-羟色胺诱导的空肠水和电解质分泌。
Gut. 1994 May;35(5):637-40. doi: 10.1136/gut.35.5.637.
6
Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action.血清素对大鼠体内回结肠转运及液体转移的影响：可能的作用机制
Gut. 1993 Jun;34(6):794-8. doi: 10.1136/gut.34.6.794.
7
Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.
Drugs. 1993 Nov;46(5):925-43. doi: 10.2165/00003495-199346050-00009.
8
Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects.ICS 205-930（一种特异性5-羟色胺3受体拮抗剂）对正常受试者固体餐胃排空的影响。
Gut. 1988 Sep;29(9):1249-52. doi: 10.1136/gut.29.9.1249.
9
Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men.5-羟色胺3受体拮抗剂（ICS 205-930）对健康男性结肠运动活性的影响。
Br J Clin Pharmacol. 1989 Sep;28(3):315-22. doi: 10.1111/j.1365-2125.1989.tb05432.x.
10
Inhibition of cholera toxin-induced intestinal secretion by the 5-HT3 receptor antagonist ICS 205-930.
Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):704-5. doi: 10.1007/BF00168665.
本文引用的文献
1
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.5-羟色胺M受体亚型的鉴定及其被一类新型药物的特异性阻断
Nature. 1985;316(6024):126-31. doi: 10.1038/316126a0.
2
Management of carcinoid tumors of the gastrointestinal tract.胃肠道类癌肿瘤的管理
Surg Gynecol Obstet. 1977 Aug;145(2):223-7.
Zotero 插件